| Authors: |
Foote HP; Department of Pediatrics, Duke University, Durham, North Carolina, USA., Hong C; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA., Anwar M; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA., Borentain M; Bayer Corporation, Whippany, New Jersey, USA., Bugin K; United States Food and Drug Administration, Silver Spring, Maryland, USA., Dreyer N; Dreyer Strategies, Newton, Massachusetts, USA., Fessel J; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA., Goyal N; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA., Hanger M; Clinical Trials Transformation Initiative Duke Clinical Research Institute, North Carolina, USA., Hernandez AF; Duke Clinical Research Institute, Durham, North Carolina, USA., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina, USA., Jackman JG; Duke Clinical Research Institute, Durham, North Carolina, USA., Lindsay AC; Janssen Pharmaceuticals, Horsham, Pennsylvania, USA., Matheny ME; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ozer K; Novo Nordisk, Plainsboro, New Jersey, USA., Seidel J; Boehringer Ingelheim, Plainsboro, New Jersey, USA., Stockbridge N; United States Food and Drug Administration, Silver Spring, Maryland, USA., Embi PJ; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Lindsell CJ; Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: chris.lindsell@duke.edu. |
